Date Range
Date Range
Date Range
An attractive EBITDA profile, and. 725m of revenue in 2016. We have a strong, clearly defined vision for the future called Vision 2022. To deliver on our Vision 2022 goals. Employs approximately 1,400 people worldwide. Acquired Novel Ingredients in August 2017 and NutraGenesis in November 2017.
Code of Business Conduct and Ethics. Board Committee Composition and Charters. Contact the Board of Directors. Investigator Conflict of Interest Policy. Inovio is revolutionizing the fight against cancer and infectious diseases. Inovio Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call August 10, 2015. 2Q 2015 Financial Results Conference Call.
GTCR Completes Acquisition of Inteliquent. Inteliquent Reports Third Quarter 2016 Results.